Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy +/- Paclitaxel in Inoperable Esophageal Cancer
NCT00008047Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Aug 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in esophageal cancer, sponsored by GERCOR. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00008047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008047.